Hedera Dx is dedicated to transforming oncology by providing cutting-edge liquid biopsy solutions that improve patient experiences, outcomes and journeys, as well as healthcare professional experiences, while facilitating the prescription, discovery and development of the next breakthrough precision oncology therapies.

Hedera Dx aims to make liquid biopsies globally accessible for patients by enabling routine use of validated liquid biopsies in-house without compliance, bioinformatics, and reporting hurdles at all stages of the disease. They focus on customer- and patient-centric approaches, including integration of Patient-Reported Outcomes (PROs), Patient-Reported Experience Measures (PREMs), and feedback from patient groups and customers. Their liquid biopsy solutions enable non-invasive blood-based diagnostics for cancer patients to facilitate better and timely treatment options.

The company offers a unique customer experience by partnering with laboratories and clinicians to provide fast, locally CE-IVDR compliant, and clinically actionable NGS-based liquid biopsy solutions. Their products include the registered CE-IVD medical device software Hedera Prime and the pan-cancer targeted assay Hedera Profiling 2 ctDNA test panel for hospital laboratories.

Hedera Dx also supports patients with tools and programs such as patient apps to help understand, treat, and monitor cancer, aiming to improve patients' quality of life.

Founded in Switzerland in 2021, Hedera Dx is backed by leading investors and established by Tommi Lehtonen, Damien Lapray, and Christian Meisel. Key team members include CEO and Co-founder Tommi Lehtonen, CMO and Co-founder Christian Meisel, and CCO and Co-founder Damien Lapray, along with directors leading engineering, assay development, bioinformatics, sales, and finance.

Hedera Dx is headquartered at Route de la Corniche 5, Bâtiment Alanine, Epalinges, Vaud 1066, Switzerland. They maintain an active presence on LinkedIn and regularly publish news and announcements about their advancements and clinical studies.

No job postings were found on their official career page at the time of checking: https://hederadx.teamtailor.com/jobs